CORC

在结果中检索

CORC

浏览/检索结果: 共19条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/04
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Li, X.;  Bi, L.;  Li, Y.;  He, L.;  Xu, H.
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 页码: 227-234
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：7/0  |  提交时间：2019/11/19
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2, 页码: 227-234
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
Efficacy and Safety of Novel Targeted Synthetic DMARD and Biological DMARD in Active Psoriatic Arthritis: A Systematic Review, Meta-Analysis, and Network Meta-Analysis 期刊论文
ARTHRITIS & RHEUMATOLOGY, 2018, 卷号: Vol.70
作者:  Lu, Chenyang;  Wallace, Beth I.;  Fu, Wenyi;  Liu, Yi
收藏  |  浏览/下载：6/0  |  提交时间：2019/02/25
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study 期刊论文
CLINICAL RHEUMATOLOGY, 2017, 卷号: 36, 期号: 1
作者:  Liu, Yi;  Li, Juan;  Wu, Lijun;  He, Dongyi;  Liu, Tian
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study 期刊论文
CLINICAL RHEUMATOLOGY, 2017, 卷号: 36, 页码: 35-43
作者:  An, Yuan;  Liu, Tian;  He, Dongyi;  Wu, Lijun;  Li, Juan
收藏  |  浏览/下载：2/0  |  提交时间：2019/11/26
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT) A multicenter randomized clinical trial 期刊论文
MEDICINE, 2016, 卷号: 95, 期号: 28
作者:  Li, Ru;  Zhao, Jin-Xia;  Su, Yin;  He, Jing;  Chen, Li-Na
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace